🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
Evaluate the effects of PEA supplementation on disease activity, health-rel...
Status
Not Yet Recruiting
Location
Internal Medicine and Gastroenterology clinic, El-Demerdash Hospital
Start Date
2026-08-15
Trial ID
NCT07609810
Treatments Being Tested
This phase II study will assess the effect of a treatment combination of Ri...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-05-02
Trial ID
NCT02789397
Treatments Being Tested
Phase III, comparative, multicenter, randomized, controlled, double-blind a...
Status
Completed
Location
Hôpital Cochin
Start Date
2016-12-05
Trial ID
NCT02807103
Treatments Being Tested
This is a Randomized, Double-Blind, Placebo-Controlled Study designed to as...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT06226662
The purpose of this study is to assess the efficacy and safety of tocilizum...
Status
Completed
Location
Seoul National Univ. Hospital
Start Date
2009-10
Trial ID
NCT01211834
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-07-12
Trial ID
NCT01639339
Treatments Being Tested
This is a Phase 2 study. All patients will receive prednisolone and AZA as ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-11
Trial ID
NCT04371718
The primary aim is to study the efficacy of treatment with BDB-001 Injectio...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-11-10
Trial ID
NCT07168161
Treatments Being Tested
The purpose of this study is to initially access the safety and effectivity...
Status
Completed
Location
Remegen，ltd.
Start Date
2019-10-16
Trial ID
NCT04082416
Treatments Being Tested